DYN
Price
$25.80
Change
+$0.50 (+1.98%)
Updated
May 1, 6:59 PM EST
Earnings call today
KYMR
Price
$36.20
Change
+$2.57 (+7.64%)
Updated
May 1, 6:59 PM EST
One day until earnings call
Ad is loading...

Compare predictions DYN vs KYMR

Header iconDYN vs KYMR Comparison
Open Charts DYN vs KYMRBanner chart's image
Dyne Therapeutics
Price$25.80
Change+$0.50 (+1.98%)
Volume$818.1K
CapitalizationN/A
Kymera Therapeutics
Price$36.20
Change+$2.57 (+7.64%)
Volume$362.26K
CapitalizationN/A
View a ticker or compare two or three
DYN vs KYMR Comparison Chart

Loading...

DYNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
KYMRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
DYN vs. KYMR commentary
May 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Hold and KYMR is a Hold.

COMPARISON
Comparison
May 02, 2024
Stock price -- (DYN: $25.31 vs. KYMR: $33.62)
Brand notoriety: DYN and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 43% vs. KYMR: 78%
Market capitalization -- DYN: $2.23B vs. KYMR: $2.22B
DYN [@Biotechnology] is valued at $2.23B. KYMR’s [@Biotechnology] market capitalization is $2.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $578.54B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • DYN’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, both DYN and KYMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 4 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • DYN’s TA Score: 4 bullish, 4 bearish.
  • KYMR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DYN is a better buy in the short-term than KYMR.

Price Growth

DYN (@Biotechnology) experienced а -0.51% price change this week, while KYMR (@Biotechnology) price change was -5.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.37%. For the same industry, the average monthly price growth was -4.20%, and the average quarterly price growth was +1241.07%.

Reported Earning Dates

DYN is expected to report earnings on Aug 01, 2024.

KYMR is expected to report earnings on Aug 02, 2024.

Industries' Descriptions

@Biotechnology (+3.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for DYN with price predictions.
OPEN
A.I.dvisor published
a Summary for KYMR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
KYMR($2.22B) and DYN($2.17B) have the same market capitalization . DYN YTD gains are higher at: 90.301 vs. KYMR (32.050).
DYNKYMRDYN / KYMR
Capitalization2.17B2.22B98%
EBITDAN/AN/A-
Gain YTD90.30132.050282%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
DYNKYMR
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
DYNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
KYMRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AWPYX18.98-0.23
-1.20%
AB Sustainable Intl Thematic Advisor
GSIYX22.08-0.27
-1.21%
Goldman Sachs GQG Ptnrs Intl Opps R6
AIWCX11.37-0.15
-1.30%
American Century International Gr C
AFJCX18.03-0.24
-1.31%
Virtus NFJ International Value C
MSTSX10.60-0.15
-1.40%
Morningstar Global Opportunistic Equity

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
-0.59%
RNA - DYN
45%
Loosely correlated
-2.31%
KYMR - DYN
44%
Loosely correlated
-3.00%
AXON - DYN
43%
Loosely correlated
+0.11%
KROS - DYN
42%
Loosely correlated
-3.80%
FULC - DYN
42%
Loosely correlated
+0.71%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with INBX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then INBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-3.00%
INBX - KYMR
47%
Loosely correlated
-0.35%
ARVN - KYMR
45%
Loosely correlated
-0.41%
DYN - KYMR
44%
Loosely correlated
-0.59%
EDIT - KYMR
43%
Loosely correlated
-2.98%
AXON - KYMR
42%
Loosely correlated
+0.11%
More